
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | $5.2M | $19.9M | |
Selling, General & Admin | -- | -- | -- | $1.7M | $5.2M | |
Other Inc / (Exp) | -- | -- | -- | -- | -$5K | |
Operating Expenses | -- | -- | -- | $6.9M | $25.1M | |
Operating Income | -- | -- | -- | -$6.9M | -$25.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -$7.1M | -$21M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -$7.1M | -$21M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$7.1M | -$21M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$0.24 | -$0.40 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.24 | -$0.40 | |
Weighted Average Basic Share | -- | -- | -- | $29.4M | $41.7M | |
Weighted Average Diluted Share | -- | -- | -- | $29.4M | $41.7M | |
EBITDA | -- | -- | -- | -$6.9M | -$21M | |
EBIT | -- | -- | -- | -$6.9M | -$21M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -$6.9M | -$25.1M | |
Operating Income (Adjusted) | -- | -- | -- | -$6.9M | -$21M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | $69.5M | |
Selling, General & Admin | -- | -- | -- | -- | $13.4M | |
Other Inc / (Exp) | -- | -- | -- | -- | -$5K | |
Operating Expenses | -- | -- | -- | -- | $82.9M | |
Operating Income | -- | -- | -- | -- | -$82.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -$78.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -$78.9M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$2.86 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$2.86 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -$77.5M | |
EBIT | -- | -- | -- | -- | -$77.5M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -$82.9M | |
Operating Income (Adjusted) | -- | -- | -- | -- | -$77.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | $5.2M | $19.9M | |
Selling, General & Admin | -- | -- | -- | $1.7M | $5.2M | |
Other Inc / (Exp) | -- | -- | -- | -- | -$5K | |
Operating Expenses | -- | -- | -- | $6.9M | $25.1M | |
Operating Income | -- | -- | -- | -$6.9M | -$25.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -$7.1M | -$21M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -$7.1M | -$21M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$7.1M | -$21M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$0.24 | -$0.40 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.24 | -$0.40 | |
Weighted Average Basic Share | -- | -- | -- | $29.4M | $41.7M | |
Weighted Average Diluted Share | -- | -- | -- | $29.4M | $41.7M | |
EBITDA | -- | -- | -- | -$6.9M | -$21M | |
EBIT | -- | -- | -- | -$6.9M | -$21M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -$6.9M | -$25.1M | |
Operating Income (Adjusted) | -- | -- | -- | -$6.9M | -$21M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | -- | $61.6M | |
Short Term Investments | -- | -- | -- | -- | $314.1M | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | $1.2M | |
Total Current Assets | -- | -- | -- | -- | $376.9M | |
Property Plant And Equipment | -- | -- | -- | -- | $1M | |
Long-Term Investments | -- | -- | -- | -- | $18.1M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | $43K | |
Total Assets | -- | -- | -- | -- | $396M | |
Accounts Payable | -- | -- | -- | -- | $3.5M | |
Accrued Expenses | -- | -- | -- | -- | $1.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $213K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | -- | -- | $13M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | -- | $13.8M | |
Common Stock | -- | -- | -- | -- | $3M | |
Other Common Equity Adj | -- | -- | -- | -- | -$41K | |
Common Equity | -- | -- | -- | -- | $379.3M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -- | -- | $382.2M | |
Total Liabilities and Equity | -- | -- | -- | -- | $396M | |
Cash and Short Terms | -- | -- | -- | -- | $375.6M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | $27.7M | $83.6M | |
Short Term Investments | -- | -- | -- | -- | $265.5M | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | $3M | |
Total Current Assets | -- | -- | -- | $27.7M | $352.1M | |
Property Plant And Equipment | -- | -- | -- | -- | $973K | |
Long-Term Investments | -- | -- | -- | -- | $24M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | $488K | $103K | |
Total Assets | -- | -- | -- | $28.2M | $377.1M | |
Accounts Payable | -- | -- | -- | $5.9M | $3.5M | |
Accrued Expenses | -- | -- | -- | $1.1M | $4.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $283K | |
Other Current Liabilities | -- | -- | -- | $56K | $1.4M | |
Total Current Liabilities | -- | -- | -- | $7.2M | $11.7M | |
Long-Term Debt | -- | -- | -- | $25M | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | $35.3M | $12.4M | |
Common Stock | -- | -- | -- | $1K | $3M | |
Other Common Equity Adj | -- | -- | -- | -- | -$6K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | $2.9M | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -- | -$7.1M | $364.7M | |
Total Liabilities and Equity | -- | -- | -- | $28.2M | $377.1M | |
Cash and Short Terms | -- | -- | -- | $27.7M | $349.1M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | $85K | $5M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$7.1M | -$21M | |
Depreciation & Amoritzation | -- | -- | -- | -- | $16K | |
Stock-Based Compensation | -- | -- | -- | $85K | $4.9M | |
Change in Accounts Receivable | -- | -- | -- | $1K | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$168K | -$20.9M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | $42.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $25M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | $27.9M | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | $61.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | $27.7M | $22M | |
Ending Cash (CF) | -- | -- | -- | $27.7M | $83.6M | |
Levered Free Cash Flow | -- | -- | -- | -$168K | -$20.9M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.